A business in context

AUPH research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-21 · 0001837798-26-000013

  2. 8-K · Current report

    Report date 2026-08-19 · 0001600620-26-000066 · Items 8.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001600620-26-000062

  4. 8-K · Current report

    Report date 2026-08-06 · 0001600620-26-000059 · Items 2.02,9.01

  5. 4 · Ownership change

    Report date 2026-06-04 · 0001896369-26-000002

  6. 4 · Ownership change

    Report date 2026-06-04 · 0001500210-26-000002

  7. 4 · Ownership change

    Report date 2026-06-04 · 0001370348-26-000002

  8. 4 · Ownership change

    Report date 2026-06-04 · 0001302605-26-000002

  9. 8-K · Current report

    Report date 2026-06-03 · 0001600620-26-000053 · Items 5.07,9.01

  10. 4 · Ownership change

    Report date 2026-05-29 · 0001178579-26-000004

  11. 4 · Ownership change

    Report date 2026-05-18 · 0002126966-26-000003

  12. 4 · Ownership change

    Report date 2026-05-18 · 0001837798-26-000005

  13. 8-K · Current report

    Report date 2026-05-08 · 0001140361-26-020402 · Items 2.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001600620-26-000049

  15. 8-K · Current report

    Report date 2026-05-07 · 0001600620-26-000048 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-03 · 0001600620-26-000039

  17. 8-K · Current report

    Report date 2026-03-30 · 0001600620-26-000035 · Items 1.01,7.01,9.01

  18. 8-K · Current report

    Report date 2026-03-20 · 0001600620-26-000026 · Items 5.02,9.01

  19. 10-K · Annual report

    Report date 2025-12-31 · 0001600620-26-000017

  20. 8-K · Current report

    Report date 2026-02-26 · 0001600620-26-000015 · Items 2.02

  21. 8-K · Current report

    Report date 2025-11-04 · 0001600620-25-000108 · Items 2.02

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001600620-25-000106

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001600620-25-000092

  24. 8-K · Current report

    Report date 2025-07-31 · 0001600620-25-000090 · Items 2.02,8.01,9.01

  25. 8-K · Current report

    Report date 2025-06-30 · 0001600620-25-000083 · Items 8.01

  26. 8-K · Current report

    Report date 2025-05-15 · 0001600620-25-000057 · Items 5.02,5.03,5.07

  27. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001600620-25-000049

  28. 8-K · Current report

    Report date 2025-05-12 · 0001600620-25-000047 · Items 2.02

  29. DEF 14A · Proxy statement

    Report date 2025-05-15 · 0001600620-25-000032

  30. 10-K · Annual report

    Report date 2024-12-31 · 0001600620-25-000011

  31. 8-K · Current report

    Report date 2025-02-27 · 0001600620-25-000009 · Items 2.02

  32. SC 13G/A · Ownership disclosure

    0001172661-24-005289

  33. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001600620-24-000108

  34. 8-K · Current report

    Report date 2024-11-07 · 0001600620-24-000106 · Items 2.02,2.05,5.02,9.01

  35. 8-K · Current report

    Report date 2024-09-09 · 0001600620-24-000099 · Items 5.02,5.03,7.01,9.01

  36. SC 13D · Ownership disclosure

    0001214659-24-016381

  37. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001600620-24-000091

  38. 8-K · Current report

    Report date 2024-08-01 · 0001600620-24-000089 · Items 2.02,9.01

  39. 8-K · Current report

    Report date 2024-06-14 · 0001600620-24-000087 · Items 5.07,9.01

  40. DEF 14A · Proxy statement

    Report date 2024-06-14 · 0001600620-24-000064

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 5 transaction rows5PSale: 0 transaction rows0SGrant / award: 9 transaction rows9AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

15 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-04
2026-06-08
Goetz KathleenA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
23931.00.0
2026-06-04
2026-06-08
Bailey Jeffrey AllenA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
23931.00.0
2026-06-04
2026-06-08
Johnson Craig AA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
23931.00.0
2026-06-04
2026-06-08
Nova Tina SusanA · Grant / award
Acquired
Director Stock Option (right to buy)
Derivative security
23931.00.0
2026-06-02
2026-06-02
TANG CAPITAL MANAGEMENT LLC; TANG KEVINP · Purchase
Acquired
Common Shares206005.015.28
2026-06-02
2026-06-02
TANG CAPITAL MANAGEMENT LLC; TANG KEVINJ · Other (see filing)
Acquired
Short Put Options (potential obligation to buy)
Derivative security
10000.01.65
2026-06-01
2026-06-02
TANG CAPITAL MANAGEMENT LLC; TANG KEVINP · Purchase
Acquired
Common Shares343521.015.28
2026-06-01
2026-06-02
TANG CAPITAL MANAGEMENT LLC; TANG KEVINP · Purchase
Acquired
Common Shares99.015.34
2026-05-29
2026-06-02
TANG CAPITAL MANAGEMENT LLC; TANG KEVINP · Purchase
Acquired
Common Shares2299.015.35
2026-05-29
2026-06-02
TANG CAPITAL MANAGEMENT LLC; TANG KEVINP · Purchase
Acquired
Common Shares262682.015.31
2026-05-18
2026-05-20
Cole RyanA · Grant / award
Acquired
Common Stock116144.00.0
2026-05-18
2026-05-20
Cole RyanA · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
70230.00.0
2026-05-18
2026-05-20
Robertson Stephen P.A · Grant / award
Acquired
Common Stock115541.00.0
2026-05-18
2026-05-20
Hearne Michael SA · Grant / award
Acquired
Common Stock116144.00.0
2026-05-18
2026-05-20
Hearne Michael SA · Grant / award
Acquired
Employee Stock Option (right to buy)
Derivative security
70230.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001600620Aurinia Pharmaceuticals Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    Year endedReported USD revenueCPI-adjusted USD revenue
    2024-12-31$235.13M$250.29M
    2023-12-31$175.51M$192.33M
    2022-12-31$134.03M$152.90M
    2021-12-31$45.60M$56.19M
    2020-12-31$50.12M$64.66M
    2019-12-31$318.0K$415.3K
    2018-12-31$463.0K$615.7K

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗